none91Background: The long pentraxin PTX3 is a key component of the humoral arm of innate immunity related to sepsis severity and mortality. We evaluated the clinical and prognostic significance of circulating PTX3 in the largest cohort ever reported of patients with severe sepsis or septic shock. Materials and methods: Plasma PTX3 was measured on days 1, 2 and 7 after randomization of 958 patients to albumin or crystalloids for fluid resuscitation in the multicentre Albumin Italian Outcome Sepsis (ALBIOS) trial. We tested the association of PTX3 and its changes over time with clinical severity, prevalent and incident organ dysfunctions, 90-day mortality and treatment. Results: PTX3 was high at baseline (72 [33–186] ng/mL) and rose with the...
OBJECTIVE: To evaluate the recently discovered long pentraxin PTX3 in plasma of critically ill patie...
Sepsis, which is the leading cause of death in intensive care units (ICU), has been acknowledged as ...
Sepsis, which is the leading cause of death in intensive care units (ICU), has been acknowledged as ...
Background: The long pentraxin PTX3 is a key component of the humoral arm of innate immunity related...
Background: The long pentraxin PTX3 is a key component of the humoral arm of innate immunity related...
PURPOSE: Pentraxin 3 (PTX3) is an inflammatory mediator produced by neutrophils, macrophages, myeloi...
Background Early diagnostic and prognostic stratification of patients with suspected infection is...
Sepsis, which is the leading cause of death in intensive care units (ICU), has been acknowledged as ...
Background: Pentraxin-3 (PTX-3) is an acute-phase protein involved in inflammatory and infectious pr...
Introduction Long pentraxin 3 (PTX3) is an acute-phase protein secreted by various cells, including...
Background: Sepsis is the leading cause of mortality in intensive care units (ICUs). However, early ...
The first line of defense in innate immunity is provided by cellular and humoral mediators. Pentraxi...
PURPOSE: Pentraxin 3 (PTX3) has been suggested to be a prognostic marker of mortality in severe seps...
Objective: To evaluate the usefulness of a new marker, pentraxin, as a prognostic marker in septic ...
OBJECTIVE: To evaluate the recently discovered long pentraxin PTX3 in plasma of critically ill patie...
Sepsis, which is the leading cause of death in intensive care units (ICU), has been acknowledged as ...
Sepsis, which is the leading cause of death in intensive care units (ICU), has been acknowledged as ...
Background: The long pentraxin PTX3 is a key component of the humoral arm of innate immunity related...
Background: The long pentraxin PTX3 is a key component of the humoral arm of innate immunity related...
PURPOSE: Pentraxin 3 (PTX3) is an inflammatory mediator produced by neutrophils, macrophages, myeloi...
Background Early diagnostic and prognostic stratification of patients with suspected infection is...
Sepsis, which is the leading cause of death in intensive care units (ICU), has been acknowledged as ...
Background: Pentraxin-3 (PTX-3) is an acute-phase protein involved in inflammatory and infectious pr...
Introduction Long pentraxin 3 (PTX3) is an acute-phase protein secreted by various cells, including...
Background: Sepsis is the leading cause of mortality in intensive care units (ICUs). However, early ...
The first line of defense in innate immunity is provided by cellular and humoral mediators. Pentraxi...
PURPOSE: Pentraxin 3 (PTX3) has been suggested to be a prognostic marker of mortality in severe seps...
Objective: To evaluate the usefulness of a new marker, pentraxin, as a prognostic marker in septic ...
OBJECTIVE: To evaluate the recently discovered long pentraxin PTX3 in plasma of critically ill patie...
Sepsis, which is the leading cause of death in intensive care units (ICU), has been acknowledged as ...
Sepsis, which is the leading cause of death in intensive care units (ICU), has been acknowledged as ...